NCT00776828View on ClinicalTrials.gov

The Efficacy of CILostazol ON Ischemic Complications After DES Implantation

PHASE4CompletedINTERVENTIONAL
Enrollment

960

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Coronary Artery Disease
Interventions
DRUG

cilostazol

Pletaal (Otsuka Pharm.) 100mg bid for six months

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT00776828 - The Efficacy of CILostazol ON Ischemic Complications After DES Implantation | Biotech Hunter | Biotech Hunter